Principal Financial Group Inc Amneal Pharmaceuticals, Inc. Transaction History

Principal Financial Group Inc

$172 Billion
Q4 2024

A detailed history of Principal Financial Group Inc transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 96,835 shares of AMRX stock, worth $760,154. This represents 0.0% of its overall portfolio holdings.

Number of Shares

96,835

Holding current value

$760,154

% of portfolio

0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 31, 2025	BUY	$7.69 - $9.25 $744,661 - $895,723	96,835 New	96,835 $766,000
Q3 2024 Oct 31, 2024	SELL	$6.42 - $8.83 $31,740 - $43,655	-4,944 Reduced 5.28%	88,622 $737,000
Q2 2024 Jul 29, 2024	SELL	$5.36 - $7.11 $88,541 - $117,450	-16,519 Reduced 15.01%	93,566 $594,000
Q1 2024 Apr 29, 2024	BUY	$5.24 - $6.34 $312,676 - $378,314	59,671 Added 118.36%	110,085 $667,000
Q4 2023 Feb 07, 2024	SELL	$3.36 - $6.21 $13,500 - $24,951	-4,018 Reduced 7.38%	50,414 $306,000
Q3 2023 Nov 02, 2023	BUY	$2.76 - $4.59 $14,053 - $23,372	5,092 Added 10.32%	54,432 $229,000
Q2 2023 Aug 07, 2023	SELL	$1.33 - $3.1 $15,993 - $37,277	-12,025 Reduced 19.6%	49,340 $152,000
Q1 2023 May 09, 2023	SELL	$1.27 - $2.7 $11,261 - $23,940	-8,867 Reduced 12.63%	61,365 $85,000
Q4 2022 Feb 09, 2023	BUY	$1.96 - $2.61 $32,024 - $42,644	16,339 Added 30.32%	70,232 $139,000
Q3 2022 Nov 09, 2022	SELL	$2.02 - $3.62 $77,182 - $138,316	-38,209 Reduced 41.49%	53,893 $109,000
Q2 2022 Aug 10, 2022	SELL	$3.01 - $4.46 $34,509 - $51,133	-11,465 Reduced 11.07%	92,102 $293,000
Q1 2022 May 09, 2022	SELL	$3.9 - $4.89 $134,448 - $168,577	-34,474 Reduced 24.97%	103,567 $432,000
Q4 2021 Feb 09, 2022	SELL	$3.95 - $5.85 $237,268 - $351,397	-60,068 Reduced 30.32%	138,041 $661,000
Q3 2021 Nov 09, 2021	SELL	$4.31 - $5.64 $1,215 - $1,590	-282 Reduced 0.14%	198,109 $1.06 Million
Q2 2021 Aug 10, 2021	BUY	$5.12 - $6.82 $309,862 - $412,746	60,520 Added 43.9%	198,391 $1.02 Million
Q1 2021 May 10, 2021	BUY	$4.74 - $7.38 $24,894 - $38,759	5,252 Added 3.96%	137,871 $928,000
Q4 2020 Feb 08, 2021	SELL	$3.95 - $5.42 $156,657 - $214,957	-39,660 Reduced 23.02%	132,619 $606,000
Q3 2020 Nov 06, 2020	BUY	$3.54 - $5.27 $207,755 - $309,285	58,688 Added 51.67%	172,279 $668,000
Q2 2020 Aug 05, 2020	BUY	$2.87 - $5.46 $56,607 - $107,693	19,724 Added 21.01%	113,591 $541,000
Q1 2020 May 12, 2020	BUY	$2.46 - $5.35 $7,677 - $16,697	3,121 Added 3.44%	93,867 $327,000
Q4 2019 Feb 05, 2020	BUY	$2.65 - $5.56 $60,038 - $125,967	22,656 Added 33.27%	90,746 $437,000
Q3 2019 Nov 13, 2019	BUY	$2.29 - $7.1 $14,218 - $44,083	6,209 Added 10.03%	68,090 $198,000
Q2 2019 Aug 12, 2019	BUY	$6.44 - $14.29 $273,204 - $606,224	42,423 Added 218.02%	61,881 $444,000
Q1 2019 May 10, 2019	BUY	$11.87 - $14.84 $35,289 - $44,119	2,973 Added 18.03%	19,458 $276,000
Q4 2018 Feb 14, 2019	BUY	$13.09 - $21.49 $50,304 - $82,586	3,843 Added 30.4%	16,485 $223,000
Q3 2018 Nov 14, 2018	BUY	$16.4 - $24.27 $207,328 - $306,821	12,642 New	12,642 $281,000

Others Institutions Holding AMRX

# of Institutions

194

Shares Held

141M

Call Options Held

57K

Put Options Held

49K

View Full List

About Amneal Pharmaceuticals, Inc.

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.19B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

More about AMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account

Principal Financial Group Inc Amneal Pharmaceuticals, Inc. Transaction History